Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-13

Clinical Trial Update: Memantine and Antipsychotics Use [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating memantine use with antipsychotics for Alzheimer's disease was terminated, with results posted on 2011-09-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Alzheimer's Disease | Phase 4 | Status: TERMINATED | Results posted: 2011-09-13